Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
Trial · NCT00371683
Adverse events326
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 326
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Vomiting | Gastrointestinal disorders | Apixaban 2.5mg BID | 99 | 1,596 | |
| other | Vomiting | Gastrointestinal disorders | Enoxaparin 30 mg SC Injection q 12 Hours | 102 | 1,588 | |
| other | Insomnia | Psychiatric disorders | Apixaban 2.5mg BID | 77 | 1,596 | |
| other | Insomnia | Psychiatric disorders | Enoxaparin 30 mg SC Injection q 12 Hours | 86 | 1,588 | |
| other | Dizziness | Nervous system disorders | Apixaban 2.5mg BID | 103 | 1,596 | |
| other | Dizziness | Nervous system disorders | Enoxaparin 30 mg SC Injection q 12 Hours | 88 | 1,588 | |
| other | Deep vein thrombosis | Vascular disorders | Apixaban 2.5mg BID | 127 | 1,596 | |
| other | Deep vein thrombosis | Vascular disorders | Enoxaparin 30 mg SC Injection q 12 Hours | 113 | 1,588 | |
| other | Nausea | Gastrointestinal disorders | Apixaban 2.5mg BID | 208 | 1,596 | |
| other | Nausea | Gastrointestinal disorders | Enoxaparin 30 mg SC Injection q 12 Hours | 241 | 1,588 | |
| other | Constipation | Gastrointestinal disorders | Apixaban 2.5mg BID | 227 | 1,596 | |
| other | Constipation | Gastrointestinal disorders | Enoxaparin 30 mg SC Injection q 12 Hours | 234 | 1,588 | |
| other | Oedema peripheral | General disorders | Apixaban 2.5mg BID | 131 | 1,596 | |
| other | Oedema peripheral | General disorders | Enoxaparin 30 mg SC Injection q 12 Hours | 153 | 1,588 | |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Apixaban 2.5mg BID | 84 | 1,596 | |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Enoxaparin 30 mg SC Injection q 12 Hours | 77 | 1,588 | |
| other | Pyrexia | General disorders | Apixaban 2.5mg BID | 137 | 1,596 | |
| other | Pyrexia | General disorders | Enoxaparin 30 mg SC Injection q 12 Hours | 149 | 1,588 | |
| serious | Acute coronary syndrome | Cardiac disorders | Apixaban 2.5mg BID | 0 | 1,596 | |
| serious | Acute coronary syndrome | Cardiac disorders | Enoxaparin 30 mg SC Injection q 12 Hours | 1 | 1,588 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00371683/events